CO5540388A2 - Nuevas arisulfonamidas como agentes antivirales - Google Patents
Nuevas arisulfonamidas como agentes antiviralesInfo
- Publication number
- CO5540388A2 CO5540388A2 CO03102172A CO03102172A CO5540388A2 CO 5540388 A2 CO5540388 A2 CO 5540388A2 CO 03102172 A CO03102172 A CO 03102172A CO 03102172 A CO03102172 A CO 03102172A CO 5540388 A2 CO5540388 A2 CO 5540388A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- hydroxy
- halogen
- amino
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Compuestos de fórmula general (I)R2 y R3 son iguales o distintos y representan hidrógeno, hidroxi, halógeno, nitro, ciano, trifluorometilo, trifluorometoxi, alquilo C1-C6, alcoxi C1-C6 o un grupo de fórmulaen las queR5, R6 y R7 son iguales o distintos y representan respectivamente hidrógeno o alquilo C1-C6 que a su vez puede estar sustituido con uno o dos sustituyentes seleccionados del grupo compuesto por hidroxi, halógeno, ciano, trifluorometilo y trifluorometoxi,A representa un heteroarilo de cinco o seis miembros con uno a tres heteroátomos seleccionados de N, O y/o S unido por un átomo de C con el anillo fenilo contiguo,R1 representa arilo C6-C10, heteroarilo de 5 a 10 miembros o heterociclilo de 5 a 10 miembros con uno a tres heteroátomos respectivamente seleccionados de N, O y/o S, pudiendo estar R1 sustituido con hasta tres sustituyentes seleccionados del grupo compuesto por hidroxi, amino, monoalquil (C1-C6)amino, dialquil (C1-C6)amino, halógeno, nitro, ciano, oxo, alquilo C1-C6 que a su vez puede estar sustituido con amino o hidroxi, alcoxi C1-C6, fenilo, heterociclilo de 5 ó 6 miembros con hasta dos heteroátomos seleccionados de N, O y/o S, heteroarilo de 5 ó 6 miembros con uno o más heteroátomos seleccionados de N, O y/o S, -C(O)-O-R8, -C(O)-NR9R10, -NH-C(O)-R11, -NH-C(O)-C(O)-R12 y -NH-SO2-R13,en los queR8, R9 y R10 son iguales o distintos y representan respectivamente hidrógeno o alquilo C1-C6,R9 y R10 junto con el átomo de nitrógeno al que están unidos forman un heterociclo de 5 a 6 miembros que contiene otro heteroátomo de nitrógeno u oxigeno y ...
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10119137 | 2001-04-19 | ||
| DE10148598A DE10148598A1 (de) | 2001-04-19 | 2001-10-02 | Neue Arylsulfonamide als antivirale Mittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5540388A2 true CO5540388A2 (es) | 2005-07-29 |
Family
ID=7681939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO03102172A CO5540388A2 (es) | 2001-04-19 | 2003-11-19 | Nuevas arisulfonamidas como agentes antivirales |
Country Status (9)
| Country | Link |
|---|---|
| KR (1) | KR20030088509A (es) |
| AR (1) | AR034309A1 (es) |
| CO (1) | CO5540388A2 (es) |
| DE (1) | DE10148598A1 (es) |
| EC (1) | ECSP034813A (es) |
| GT (1) | GT200200075A (es) |
| PE (1) | PE20021061A1 (es) |
| SV (1) | SV2003000995A (es) |
| ZA (1) | ZA200307892B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| CA2494164A1 (en) * | 2002-08-23 | 2004-03-04 | Rigel Pharmaceuticals, Inc. | Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
| WO2004058253A1 (en) * | 2002-12-18 | 2004-07-15 | Cytovia, Inc. | 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| DE10300109A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Methode zur Inhibition der Replikation von Herpesviren |
| US7326790B2 (en) | 2003-05-02 | 2008-02-05 | Rigel Pharmaceuticals, Inc. | Diphenylisoxazole compounds and hydro isomers thereof |
| US8580842B2 (en) | 2003-09-30 | 2013-11-12 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| WO2005049065A2 (en) | 2003-11-19 | 2005-06-02 | Rigel Pharmaceuticals, Inc. | Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections |
| US7514434B2 (en) | 2004-02-23 | 2009-04-07 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof |
| WO2007027230A2 (en) | 2005-05-02 | 2007-03-08 | Rigel Pharmaceuticals, Inc. | Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| US8486979B2 (en) | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
| UY30846A1 (es) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos |
| US20080255203A1 (en) * | 2007-04-12 | 2008-10-16 | Abbott Laboratories | Heterocyclic compounds and their methods of use |
| ES2455197T3 (es) | 2007-12-07 | 2014-04-14 | Abbvie Deutschland Gmbh & Co Kg | Derivados de oxindol 5,6-disustituidos y el uso de los mismos para la preparación de un medicamento para el tratamiento de enfermedades dependientes de vasopresina |
| BRPI0820668A2 (pt) | 2007-12-07 | 2017-08-22 | Abbott Gmbh & Co Kg | Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina |
| WO2010009775A1 (de) | 2007-12-07 | 2010-01-28 | Abbott Gmbh & Co. Kg | Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen |
| EP2231643B1 (de) | 2007-12-07 | 2012-10-31 | Abbott GmbH & Co. KG | Amidomethyl-substitutierte Oxindol-Derivate und ihre Verwendung zur Herstellung eines Medikaments zur Behandlung von Vasopressin-abhängigen Erkrankungen |
| US9040568B2 (en) | 2009-05-29 | 2015-05-26 | Abbvie Inc. | Pharmaceutical compositions for the treatment of pain |
-
2001
- 2001-10-02 DE DE10148598A patent/DE10148598A1/de not_active Withdrawn
-
2002
- 2002-04-08 KR KR10-2003-7013617A patent/KR20030088509A/ko not_active Application Discontinuation
- 2002-04-17 AR ARP020101392A patent/AR034309A1/es unknown
- 2002-04-18 GT GT200200075A patent/GT200200075A/es unknown
- 2002-04-18 PE PE2002000323A patent/PE20021061A1/es not_active Application Discontinuation
- 2002-04-18 SV SV2002000995A patent/SV2003000995A/es not_active Application Discontinuation
-
2003
- 2003-10-09 ZA ZA200307892A patent/ZA200307892B/en unknown
- 2003-10-17 EC EC2003004813A patent/ECSP034813A/es unknown
- 2003-11-19 CO CO03102172A patent/CO5540388A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SV2003000995A (es) | 2003-03-18 |
| ZA200307892B (en) | 2004-10-11 |
| DE10148598A1 (de) | 2002-10-24 |
| PE20021061A1 (es) | 2002-12-12 |
| KR20030088509A (ko) | 2003-11-19 |
| GT200200075A (es) | 2002-12-24 |
| AR034309A1 (es) | 2004-02-18 |
| ECSP034813A (es) | 2003-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5540388A2 (es) | Nuevas arisulfonamidas como agentes antivirales | |
| AR049739A1 (es) | Derivados de aril-piridina | |
| AR067646A1 (es) | Ariloxazoles sustituidos y su uso | |
| PE20050676A1 (es) | Quinolinas referidas a enfermedades cardiovasculares | |
| AR044909A1 (es) | Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia | |
| ES2436020T3 (es) | Derivados de sulfonamida sustituidos | |
| CO5560610A2 (es) | Derivados de yodobenzopiran-4-ona que tienen actividad fungicida | |
| AR040352A1 (es) | Derivados de indolinfenilsulfonamida | |
| CO5690585A2 (es) | Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor | |
| PE20180572A1 (es) | Derivados de piperidina 1,4-sustituidos | |
| CO5560573A2 (es) | Derivados activos de amino-ftalazinona como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| AR034475A1 (es) | Derivados de androstano antiinflamatorios | |
| AR038703A1 (es) | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 | |
| HUP0401784A2 (hu) | Heterobiciklikus szerkezetû virális polimeráz inhibitorok, eljárás az elõállításukra, köztitermékek és ezeket tartalmazó gyógyszerkészítmények | |
| ES2530943T3 (es) | Derivados de la cromenona con actividad antitumoral | |
| AR058287A1 (es) | Derivados de isoquinolina y composicion farmaceutica | |
| AR088808A2 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| CO6160307A2 (es) | Compuestos de pirazolina y su uso y composiciones farmaceuticas | |
| AR055744A1 (es) | Derivados de acido pirimidincarboxilico, su uso para preparar medicamentos y preparacion de dicjhos compuestos | |
| AR069417A1 (es) | Piperidinas heteroaril - sustituidas | |
| AR066669A1 (es) | Derivados de imidazolona como inhibidores de bencimidazolona quimasa. composiciones farmaceuticas. | |
| AR066606A1 (es) | Compuestos de heteroarilamida pirimidona | |
| ES2334565T3 (es) | Agonistas inversos del receptor cb 1. | |
| AR048974A1 (es) | Derivados sustituidos del dioxido de oxazol-benzoisotiazol y composiciones farmaceuticas. | |
| AR053340A1 (es) | Derivados de trifluormetilbenzamida y sus usos terapeuticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |